卡托普利长期治疗中重度高血压。
Long-term captopril treatment in moderate to severe hypertension.
作者信息
Santucci A, Aguglia F, De Mattia G, Ficara C, Balsano F
出版信息
Br J Clin Pharmacol. 1982;14 Suppl 2(Suppl 2):77S-79S. doi: 10.1111/j.1365-2125.1982.tb02061.x.
Abstract
1 The long-term effects of the oral angiotensin-converting enzyme inhibitor captopril with the addition of a diuretic (chlorthalidone) were examined in 16 patients with moderate or grave hypertension. Of these, 14 had essential hypertension and two renovascular hypertension. 2 Blood pressure fell sharply in all patients and this antihypertensive effect was maintained during 2, 4, 6, 12, and 24-month follow-up periods. The efficacy of treatment was not predicted by basal values of plasma renin activity. 3 Urinary excretion of sodium and potassium increased, but the increases were never such as to modify significantly sodium and potassium serum concentration. 4 The long-term treatment was generally well tolerated.
摘要
对16例中度或重度高血压患者，研究了口服血管紧张素转换酶抑制剂卡托普利加用利尿剂（氯噻酮）的长期效果。其中14例为原发性高血压，2例为肾血管性高血压。
所有患者血压均急剧下降，且在2个月、4个月、6个月、12个月和24个月的随访期内，这种降压效果得以维持。治疗效果并非由血浆肾素活性的基础值所预测。
钠和钾的尿排泄量增加，但增加幅度从未大到足以显著改变血清钠和钾的浓度。
长期治疗总体耐受性良好。
相似文献
1
Long-term captopril treatment in moderate to severe hypertension.卡托普利长期治疗中重度高血压。
Br J Clin Pharmacol. 1982;14 Suppl 2(Suppl 2):77S-79S. doi: 10.1111/j.1365-2125.1982.tb02061.x.
2
Captopril in clinical hypertension. Changes in components of renin-angiotensin system and in body composition in relation to fall in blood pressure with a note on measurement of angiotensin II during converting enzyme inhibition.卡托普利治疗临床高血压。肾素 - 血管紧张素系统各组分及身体成分的变化与血压下降的关系，并附关于转换酶抑制期间血管紧张素II测量的说明
Br Heart J. 1980 Sep;44(3):290-6. doi: 10.1136/hrt.44.3.290.
3
Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertension.血管紧张素转换酶抑制剂卡托普利对重度高血压的急慢性影响。
Am J Cardiol. 1982 Apr 21;49(6):1467-74. doi: 10.1016/0002-9149(82)90362-9.
4
Captopril withdrawal after chronic therapy.长期治疗后停用卡托普利
Clin Exp Hypertens (1978). 1981;3(5):929-37. doi: 10.3109/10641968109033713.
5
Long-term efficacy of angiotensin-converting-enzyme inhibition with captopril in mild-to-moderate essential hypertension.卡托普利对轻度至中度原发性高血压患者进行血管紧张素转换酶抑制的长期疗效。
Br J Clin Pharmacol. 1982;14 Suppl 2(Suppl 2):121S-126S. doi: 10.1111/j.1365-2125.1982.tb02068.x.
6
Combined treatment of severe intractable hypertension with captopril and diuretic.卡托普利与利尿剂联合治疗重度顽固性高血压
Lancet. 1980 Jul 19;2(8186):105-8. doi: 10.1016/s0140-6736(80)90001-x.
7
[A new principle in long-term treatment of essential hypertension: angiotensin-converting enzyme inhibition (author's transl)].原发性高血压长期治疗的一项新原则：血管紧张素转换酶抑制（作者译）
Dtsch Med Wochenschr. 1980 Apr 11;105(15):505-9. doi: 10.1055/s-2008-1070696.
8
Prediction of sustained antihypertensive efficacy of chronic captopril therapy: relationships to immediate blood pressure response and control plasma renin activity.慢性卡托普利治疗持续降压疗效的预测：与即时血压反应及血浆肾素活性的关系
Am Heart J. 1982 Mar;103(3):384-90. doi: 10.1016/0002-8703(82)90278-2.
9
Captopril in the long-term treatment of essential hypertension: changes in the renin-angiotensin-aldosterone system.卡托普利用于原发性高血压的长期治疗：肾素-血管紧张素-醛固酮系统的变化
Am J Cardiol. 1982 Apr 21;49(6):1555-7. doi: 10.1016/0002-9149(82)90388-5.
10
Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.卡托普利与马来酸依那普利：降压及激素效应比较
J Cardiovasc Pharmacol. 1985;7 Suppl 1:S12-5.
引用本文的文献
1
Captopril for refractory hypertension in patients with impaired renal function.卡托普利用于肾功能受损患者的顽固性高血压
J R Soc Med. 1985 May;78(5):367-72. doi: 10.1177/014107688507800504.
2
Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.卡托普利。其药效学和药代动力学特性的最新进展，以及在高血压和充血性心力衰竭中的治疗应用。
Drugs. 1988 Nov;36(5):540-600. doi: 10.2165/00003495-198836050-00003.
3
Effective dose range of enalapril in mild to moderate essential hypertension.依那普利治疗轻至中度原发性高血压的有效剂量范围。
Br J Clin Pharmacol. 1985 May;19(5):605-11. doi: 10.1111/j.1365-2125.1985.tb02687.x.
本文引用的文献
1
Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension.血管紧张素转换酶抑制剂卡托普利对原发性高血压的作用。
Br J Clin Pharmacol. 1982 Feb;13(2):213-7. doi: 10.1111/j.1365-2125.1982.tb01359.x.
2
Immune-complex glomerulopathy in patients treated with captopril.接受卡托普利治疗的患者的免疫复合物性肾小球病。
Lancet. 1980 Jun 7;1(8180):1212-5. doi: 10.1016/s0140-6736(80)91677-3.
3
Captopril associated granulocytopenia in hypertension after renal transplantation.肾移植后高血压患者中卡托普利相关的粒细胞减少症
Lancet. 1980 Apr 26;1(8174):927-8. doi: 10.1016/s0140-6736(80)90854-5.
4
Captopril and agranulocytosis.卡托普利与粒细胞缺乏症
Lancet. 1980 Apr 26;1(8174):926-7. doi: 10.1016/s0140-6736(80)90853-3.
5
Radioimmunoassay for aldosterone without chromatography. 2. Determination of plasma aldosterone.无需层析的醛固酮放射免疫测定法。2. 血浆醛固酮的测定
Acta Endocrinol (Copenh). 1973 Nov;74(3):558-67. doi: 10.1530/acta.0.0740558.
6
Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.一种用于血管紧张素I的放射免疫测定法在正常人体血浆肾素活性生理测量中的应用。
J Clin Endocrinol Metab. 1969 Oct;29(10):1349-55. doi: 10.1210/jcem-29-10-1349.
7
Oral angiotensin-converting enzyme inhibitor in long-term treatment of hypertensive patients.
Ann Intern Med. 1979 Jan;90(1):19-23. doi: 10.7326/0003-4819-90-1-19.
8
Long-term treatment of hypertension in man by an orally active angiotensin-converting enzyme inhibitor.一种口服活性血管紧张素转换酶抑制剂对人类高血压的长期治疗。
Clin Sci Mol Med Suppl. 1978 Dec;4:293s-295s. doi: 10.1042/cs055293s.
Zotero 插件